公司资料
Novabay Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- NBY
- 交易所:
- AMEX
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for NBY.
公司概览
业务概览
NovaBay Pharmaceuticals is a specialty pharmaceutical company focused on eye care and skin/dermatology products. Its business has centered on commercial products and niche healthcare applications rather than broad biotech discovery.
所在地与行业分类
NovaBay is headquartered in the United States and listed on NYSE American. It sits in specialty pharma and eye-care healthcare products.
商业模式特征
The company depends on product sales, channel execution, and the ability to keep a narrow commercial portfolio relevant. Investors usually watch revenue, distribution, and strategic changes.
生物医药行业定位
NovaBay occupies a small specialty-pharma niche within healthcare. It is more commercial than development-stage biotech and tends to move on product execution.
未来催化剂
- NovaBay is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update. The market no longer treats it as a live growth name.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。